Chemical and Pharmaceutical Bulletin p. 2287 - 2293 (1996)
Update date:2022-07-31
Topics:
Matsuoka, Hiroharu
Maruyama, Noriaki
Suzuki, Hiroshi
Kuroki, Toshio
Tsuji, Keiichiro
Kato, Nobuaki
Ohi, Nobuhiro
Mihara, Masahiko
Takeda, Yasuhisa
Yano, Keiichi
Novel methotrexate (MTX) derivatives with either a mono- or dialkyl- substituted benzene ring were synthesized and initially tested for in vitro anti-proliferative activities using human peripheral blood mononuclear cells (hPBMC) derived from healthy volunteers and synovial cells (hSC) derived from patients with rheumatoid arthritis (RA). Compounds with potent activities were further evaluated in an in vivo adjuvant arthritis model. In comparison with MTX, a glutamate derivative 3a was more potent as a suppressor of the in vitro cell proliferation and the in vivo experimental arthritis, and a homoglutamate derivative, 3e, exhibited fairly good activities in vitro and considerable activity in vivo in a dose-dependent manner. As expected, 3e did not act as a substrate of folylpolyglutamate synthetase (FPGS), and thus did not undergo polyglutamation, which is thought to be responsible for side-effects that occur during MTX therapy.
View MoreZibo Kunran Enterprises Co. LTD
website:http://www.kunranchem.com
Contact:0086 533 5200669
Address:No. 96 Jinjing Avenue, Zibo, Shandong, China
Penglai Qianwei Chemical Co., Ltd.
Contact:86-535-3357802
Address:Shahelu (north), Penglai, Shandong, China
Xinjiang Zhongtai Chemical Co., Ltd.
Contact:+86-991-8788172
Address:NO.78 XISHAN RD.URUMQI，CHINA
Contact:0510-85393305
Address:1619 Huishan Avenue, Huishan District, Wuxi,
Contact:+86-571-86025531 / 86024803
Address:1218-24 Guangyin Mansion,42 Fengqi East Road
Doi:10.1021/jo01266a004
(1968)Doi:10.1016/S0040-4039(00)73957-8
(1993)Doi:10.1248/cpb.52.1367
(2004)Doi:10.1107/S0108270193007759
(1994)Doi:10.1016/0022-328X(93)83277-3
(1993)Doi:10.1016/j.bioorg.2019.103217
(2019)
